Biocryst Pharma Inc (BCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
Sales | 1,448 | 5,887 | 2,729 | 1,454 | 12,494 |
Cost of Goods | N/A | 1,399 | N/A | N/A | N/A |
Gross Profit | 1,448 | 4,488 | 2,729 | 1,454 | 12,494 |
Operating Expenses | 36,366 | 34,217 | 27,991 | 29,947 | 30,745 |
Operating Income | -34,918 | -29,330 | -25,262 | -28,493 | -18,251 |
Interest Expense | 3,035 | 2,726 | 2,414 | 2,346 | 2,195 |
Other Income | 324 | 1,002 | 244 | 1,242 | 2,000 |
Pre-tax Income | -37,629 | -31,054 | -27,432 | -29,597 | -18,446 |
Net Income Continuous | -37,629 | -31,054 | -27,432 | -29,597 | -18,446 |
Net Income | $-37,629 | $-31,054 | $-27,432 | $-29,597 | $-18,446 |
EPS Basic Total Ops | -0.34 | -0.28 | -0.25 | -0.28 | -0.19 |
EPS Basic Continuous Ops | -0.34 | -0.28 | -0.25 | -0.28 | -0.19 |
EPS Diluted Total Ops | -0.34 | -0.28 | -0.25 | -0.28 | -0.19 |
EPS Diluted Continuous Ops | -0.34 | -0.28 | -0.25 | -0.28 | -0.19 |
EBITDA(a) | $-34,351 | $-28,961 | $-24,897 | $-28,065 | $-17,773 |